Abstract
1 Strips of longitudinal muscle from rabbit intestine accumulated radioactivity when exposed to [3H]-adenosine.
2 Accumulation of radioactivity was not sodium-dependent or ouabain-sensitive, but was reduced by cooling, zero glucose plus bubbling with N2, 2,4,dinitrophenol, dipyridamole, hexobendine and lidoflazine.
3 After 7 min exposure to [3H]-adenosine, the tissue was found to contain radioactive adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate (AMP) and adenosine itself in the approximate ratio 13: 6: 4: 1.
4 In the presence of dipyridamole, hexobendine or lidoflazine (each 1 μM), the amounts of radioactive ATP, ADP, AMP and adenosine were reduced with the concentration of adenosine not significantly different from controls.
5 It is concluded that energy-dependent uptake of adenosine does not occur in the longitudinal muscle of rabbit intestine. Adenosine enters the tissue by a passive process and rapidly becomes phosphorylated giving rise to apparently high tissue: medium ratios.
6 The drugs dipyridamole, hexobendine and lidoflazine appear to reduce the accumulation of radioactivity by preventing the formation of adenosine phosphate derivatives.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Afonso S., O'Brien G. S., Crumpton C. W. Enhancement of coronary vasodilating action of ATP and adenosine by lidoflazine. Circ Res. 1968 Jan;22(1):43–48. doi: 10.1161/01.res.22.1.43. [DOI] [PubMed] [Google Scholar]
- Burnstock G., Campbell G., Satchell D., Smythe A. Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol. 1970 Dec;40(4):668–688. doi: 10.1111/j.1476-5381.1970.tb10646.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burnstock G. Purinergic nerves. Pharmacol Rev. 1972 Sep;24(3):509–581. [PubMed] [Google Scholar]
- Hopkins S. V., Goldie R. G. A species difference in the uptake of adenosine by heart. Biochem Pharmacol. 1971 Dec;20(12):3359–3365. doi: 10.1016/0006-2952(71)90440-0. [DOI] [PubMed] [Google Scholar]
- Hopkins S. V. The potentiation of the action of adenosine on the guinea-pig heart. Biochem Pharmacol. 1973 Feb 1;22(3):341–348. doi: 10.1016/0006-2952(73)90415-2. [DOI] [PubMed] [Google Scholar]
- Hulme M. E., Weston A. H. Some effects of dipyridamole, hexobendine and lidoflazine on inhibitory processes in rabbit duodenum. Br J Pharmacol. 1974 Apr;50(4):609–611. doi: 10.1111/j.1476-5381.1974.tb08598.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Iversen L. L. Neuronal uptake processes for amines and amino acids. Adv Biochem Psychopharmacol. 1970;2:109–132. [PubMed] [Google Scholar]
- Kolassa N., Pfleger K., Rummel W. Specificity of adenosine uptake into the heart and inhibition by dipyridamole. Eur J Pharmacol. 1970 Mar;9(3):265–268. doi: 10.1016/0014-2999(70)90221-9. [DOI] [PubMed] [Google Scholar]
- Kraupp O., Wolner E., Adler-Kastner L., Chirikdjian J. J., Ploszczanski B., Tuisl E. Die Wirkung von Hexobendin auf Sauerstoffverbrauch, Energetik und Substratstoffwechsel des Herzens. Arzneimittelforschung. 1966 Jun;16(6):692–697. [PubMed] [Google Scholar]
- Paton W. D., Zar M. A. The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips. J Physiol. 1968 Jan;194(1):13–33. doi: 10.1113/jphysiol.1968.sp008392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Satchell D. G., Lynch A., Bourke P. M., Burnstock G. Potentiation of the effects of exogenously applied ATP and purinergic nerve stimulation on the guinea-pig taenia coli by dipyridamole and hexobendine. Eur J Pharmacol. 1972 Sep;19(3):343–350. doi: 10.1016/0014-2999(72)90100-8. [DOI] [PubMed] [Google Scholar]
- Stafford A. Potentiation of adenosine and the adenine nucleotides by dipyridamole. Br J Pharmacol Chemother. 1966 Nov;28(2):218–227. doi: 10.1111/j.1476-5381.1966.tb01888.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weston A. H. Effects of isoprenaline and phenylephrine on energy-rich phosphate compounds and glucose-6-phosphate in smooth and cardiac muscle. Br J Pharmacol. 1971 Nov;43(3):593–603. doi: 10.1111/j.1476-5381.1971.tb07189.x. [DOI] [PMC free article] [PubMed] [Google Scholar]